Reunert Ltd buy krebskrebs
Start price
30.11.20
/
50%
€2.14
Target price
30.11.21
€3.00
Performance (%)
22.43%
End price
01.12.21
€2.62
Summary
This prediction ended on 01.12.21 with a price of €2.62. The BUY prediction by krebskrebs finished with a performance of 22.43%. A total of €0.11 was paid as dividends for this prediction. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Reunert Ltd | 3.922% | 3.922% | -11.173% | 11.189% |
| iShares Core DAX® | 2.659% | 4.844% | 23.110% | 68.731% |
| iShares Nasdaq 100 | 0.916% | -0.554% | 6.985% | 113.533% |
| iShares Nikkei 225® | 2.426% | 1.598% | 15.780% | 50.934% |
| iShares S&P 500 | 1.230% | 1.039% | 4.695% | 68.205% |
Comments by krebskrebs for this prediction
In the thread Reunert Ltd diskutieren
Buy mit Kursziel 3,0
In the thread Trading Reunert Ltd
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

